HISTOPATHOLOGICAL EXAMINATIONS PROFILE OF BLADDER DISEASES IN DR. SOETOMO GENERAL ACADEMIC HOSPITAL FROM JANUARY 2015 TO DECEMBER 2019
##plugins.themes.bootstrap3.article.main##
##plugins.themes.bootstrap3.article.sidebar##
Abstract
Objective: This study aimed to analyze the profile of bladder disease in Soetomo General Hospital based on histopathological examination. Material & Methods: This study was using secondary data. Histopathological examination data of patients with bladder disease were evaluated based on age, gender, and histopathological types. Results: There were 419 patients with bladder abnormalities. Non-neoplasm bladder diseases were found in 62 patients consisted of 56 patients (90.32%) with cystitis and 6 patients (9.67%) with glandular cystitis. Neoplastic bladder diseases were found in 357 patients and were divided into benign and malignant neoplasm. Benign neoplasms were found in 11 patients consisted of 5 patients (45.45%) with UP and 6 patients (54.54%) with IUP. Malignant neoplasms were found in 340 patients consisted of 300 patients (88.23%) with urothelial carcinoma, 26 patients (7.64%) with adenocarcinoma, 14 patients (4.12%) with SCC. Moreover, six male patients with PUNLMP were also reported. Conclusion: Histopathological examination in patients with bladder abnormalities shows that neoplastic bladder diseases (357/419, 85.20%) were more common than non-neoplastic bladder disease (62/419, 14.80%).
##plugins.themes.bootstrap3.article.details##
Bladder disease, profile
Chan T. World Health Organization classification of tumours: Pathology & genetics of tumours of the urinary system and male genital organs. Urology. 2005; 65(1): 214-215.
Umbas R, Safriadi F, Mochtar C, Djatisoesanto W, Hamid A. Urologic cancer in Indonesia. Japanese Journal of Clinical Oncology. 2015; 45(8): 708-712.
Anugrah P, Nandana P, Andari M. Insidensi Penyakit Kanker Buli-buli di RSUD Provinsi Nusa Tenggara Barat periode 2017-2018. Unram Medical Journal. 2019; 8(2): 1.
Abdih M, Djatisoesanto W, Hardjowijoto S. Profile of Bladder Transitional Cell Cancer In Soetomo Hospital Surabaya. Indonesian Journal of Urology. 2014; 21(2).
Harik L, O'Toole K. Nonneoplastic Lesions of the Prostate and Bladder. Archives of Pathology & Laboratory Medicine. 2012; 136(7): 721-734.
Flores-Mireles A, Walker J, Caparon M, Hultgren S. Urinary tract infections: epidemiology, mechanisms of infection and treatment options. Nature Reviews Microbiology. 2015; 13(5): 269-284.
Arora H, Shoskes D. The enigma of men with interstitial cystitis/bladder pain syndrome. Translational andrology and urology. 2015; 4(6).
Berry S, Bogart L, Pham C, Liu K, Nyberg L, Stoto M et al. Development, Validation and Testing of an Epidemiological Case Definition of Interstitial Cystitis/Painful Bladder Syndrome. Journal of Urology. 2010; 183(5): 1848-1852.
Rowe T, Juthani-Mehta M. Urinary tract infection in older adults. Aging Health. 2013; 9(5): 519-528.
Li R, Leslie SW. Cystitis. [Updated 2021 Feb 10]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021.
McKenney J, Amin M, Young R. Urothelial (Transitional Cell) Papilloma of the Urinary Bladder: A Clinicopathologic Study of 26 Cases. Modern Pathology. 2003; 16(7): 623-629.
Magi-Galluzzi C, Epstein J. Urothelial Papilloma of the Bladder. The American Journal of Surgical Pathology. 2004; 28(12): 1615-1620.
Limaiem F, Pandey J, Leslie SW. Inverted Urothelial Papilloma. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2021.
Cheng L, Lopez-Beltran A, MacLennan G, Montironi R, Bostwick D. Neoplasms of the Urinary Bladder. Urologic Surgical Pathology. 2020; 230-321.e19.
Kim J, Moon K, Jeong C, Kwak C, Kim H, Ku J. Papillary Urothelial Neoplasm of Low Malignant Potential (PUNLMP) After Initial TUR-BT: Comparative Analyses with Noninvasive Low-Grade Papillary Urothelial Carcinoma (LGPUC). Journal of Cancer. 2017; 8(15): 2885-2891.
Zhang XK, Wang YY, Chen JW, Qin T. Bladder papillary urothelial neoplasm of low malignant potential in Chinese: A clinical and pathological analysis. International Journal of Clinical and Experimental Pathology. E-Century Publishing Corporation. 2015; 8(5): pp. 5549–5555.
Hentschel AE, van Rhijn BWG, Bründl J, Compérat EM, Plass K, et al. Papillary urothelial neoplasm of low malignant potential (PUN-LMP): Still a meaningful histo-pathological grade category for Ta, noninvasive bladder tumors in 2019? Urol Oncol. 2020 May; 38(5): 440-448.
Miyazaki J, Nishiyama H. Epidemiology of urothelial carcinoma. International Journal of Urology. 2017; 24(10): 730-734.
Syafa’a, maulani. Angka Kejadian Karsinoma Urothelial di Bagian Patologi Anatomi RSUP dr. Mohammad Hoesin Palembang Periode Tahun 2009-2013. Majalah Kedokteran Sriwijaya. 2015; 47(1): 10-16.
Saginala K, Barsouk A, Aluru JS, Rawla P, Padala SA, Barsouk A. Epidemiology of Bladder Cancer. Med Sci (Basel). 2020 Mar 13; 8(1): 15.
Roy S, Parwani A. Adenocarcinoma of the Urinary Bladder. Archives of Pathology & Laboratory Medicine. 2011; 135(12): 1601-1605.
Dadhania, V, Czerniak, B, & Guo, C. Adenocarcinoma of the urinary bladder. American journal of clinical and experimental urology. 2015; 3(2): 51–63.
Ploeg M, Aben K, Hulsbergen-van de Kaa C, Schoenberg M, Witjes J, Kiemeney L. Clinical Epidemiology of Nonurothelial Bladder Cancer: Analysis of The Netherlands Cancer Registry. Journal of Urology. 2010; 183(3): 915-920.
Mungan N, Aben K, Schoenberg M, Visser O, Coebergh J, Witjes J et al. Gender differences in stage-adjusted bladder cancer survival. Urology. 2000; 55(6): 876-880.
Martin J, Carballido E, Ahmed A, Farhan B, Dutta R, Smith C et al. Squamous cell carcinoma of the urinary bladder: Systematic review of clinical characteristics and therapeutic approaches. Arab Journal of Urology. 2016; 14(3): 183-191.
Martin J, Jefferson F, Huang M, Sung J, Chang J, Piranviseh K et al. A California Cancer Registry Analysis of Urothelial and Non-urothelial Bladder Cancer Subtypes: Epidemiology, Treatment, and Survival. Clinical Genitourinary Cancer. 2020; 18(3): e330-e336.
Guo A, Liu A, Teng X. The pathology of urinary bladder lesions with an inverted growth pattern. Chin J Cancer Res. 2016 Feb; 28(1): 107-21.
Shokeir AA. Squamous cell carcinoma of the bladder: pathology, diagnosis and treatment. BJU Int. 2004 Jan; 93(2): 216-20.
Cumberbatch MGK, Noon AP. Epidemiology, aetiology and screening of bladder cancer. Transl Androl Urol. 2019 Feb; 8(1): 5-11.